Search

Speciality Chemicals Rhodia Expands Production of Specialty Fluorinated Derivatives

| Editor: Dominik Stephan

Speciality chemicals company Rhodia, a Solvay business, invests in its production line for specialty fluorinated aliphatic derivatives in Salindres. This decision comes in response to a growing demand from the electronics industry, speakers explained. The project’s first stage is already underway with the first additional volumes expected to be available as of September of this year.

Related Company

Rhodia invests in specialty fluorinated derivatives for the electronics and pharmaceuticals markets
Rhodia invests in specialty fluorinated derivatives for the electronics and pharmaceuticals markets
(Picture: Rhodia )

Lyon/France – “With this expanded capacity, Rhodia is strengthening its role as a major innovative player in rapidly expanding markets while supporting the growth of its clients through this ambitious project,” affirms Alessandro Chiovato, Director of the Crop Protection, Health & Electronics BU.

The company currently expands its production capacity for triflic acid and anhydride (TA, TAA), as well as for Lithium bis(trifluoromethanesulfonyl)imide (LiTFSI), to meet the rapidly expanding requirements of electronic applications (such as antistatic applications for flat screens, ionic liquids and liquid crystals), the battery market (for automobiles and computers) and the pharmaceuticals market. The goal of these measures is to double the the capacity of Rhodia's entire fluorinated derivatives production pipeline at both Salindres in France and in China, group speakers stated.

This article is protected by copyright. You want to use it for your own purpose? Contact us at support.vogel.de (ID: 34844960)